Doctor profile · Federal record

Dr. Dejuania Brown-Rawls, D.O.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Myrtle Beach, SC

  • NPI 1730379132
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 22 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
8121 Rourk St
Myrtle Beach, SC 295724128
(843) 692-5000
fax (843) 692-5010
Additional location
817 Farrar Dr
Conway, SC 295268747
(843) 234-1660
fax (843) 234-1661

Credentials & registration

NPPES · NUCC
NPI registered
July 2007 — 19 yrs on file
Profile last updated
July 30, 2024
Year of graduation
2004 — 22 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
South Carolina #39906

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1730379132. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
203,288
Distinct HCPCS
10
Medicare allowed
$3,518,283
HCPCS Description Services Patients Avg allowed
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram 23,220 27 $1
J9271 Injection, pembrolizumab, 1 mg 21,409 31 $54
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 20,250 181 $0
J0897 Injection, denosumab, 1 mg 15,420 113 $23
J1453 Injection, fosaprepitant, 1 mg 12,900 27 $0
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 12,750 14 $0
J1437 Injection, ferric derisomaltose, 10 mg 12,500 104 $21
J9267 Injection, paclitaxel, 1 mg 10,840 22 $0
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 9,640 80 $7
J9299 Injection, nivolumab, 1 mg 6,841 11 $30

In context: peer comparison

Among 5 peers in this city , average services per provider: 1,876. This provider delivers 108× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,375
Transactions
29
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Adaptive Biotechnologies Corporation 2 $172.71
GlaxoSmithKline, LLC. 2 $145.44
Novartis Pharmaceuticals Corporation 4 $141.41
EMD Serono, Inc. 1 $125.34
AstraZeneca Pharmaceuticals LP 1 $121.48
Merck Sharp & Dohme LLC 2 $65.71
Celgene Corporation 3 $57.60
JAZZ PHARMACEUTICALS INC. 2 $56.49
Novocure Inc. 2 $54.39
Daiichi Sankyo Inc. 2 $47.83
Regeneron Healthcare Solutions, Inc. 2 $47.29
E.R. Squibb & Sons, L.L.C. 2 $35.29
ARRAY BIOPHARMA INC 2 $30.30
Genentech USA, Inc. 1 $28.15
Deciphera Pharmaceuticals Inc. 1 $28.08

By nature of payment

Food and Beverage
$1,375

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
600
Patients
96
Total drug cost
$2,384,913
Drug Type Claims Patients Total cost
Anastrozole Generic 186 62 $5,564
Imbruvica (Ibrutinib) Brand 48 0 $791,935
Lenalidomide Generic 46 0 $525,874
Acyclovir Generic 42 0 $956
Revlimid (Lenalidomide) Brand 38 0 $690,086
Hydroxyurea Generic 31 12 $1,104
Xarelto (Rivaroxaban) Brand 31 11 $35,154
Gabapentin Generic 30 0 $350
Letrozole Generic 26 11 $755
Verzenio (Abemaciclib) Brand 23 0 $315,199

Frequently asked questions

Auto-generated from federal data
What is Dr. Dejuania Brown-Rawls's medical specialty?
Dr. Dejuania Brown-Rawls practices Hematology & Oncology Physician in Myrtle Beach, SC.
Where does Dr. Dejuania Brown-Rawls practice?
Dr. Dejuania Brown-Rawls practices at 8121 Rourk St, Myrtle Beach, SC 295724128. Office phone: 8436925000.
What is Dr. Dejuania Brown-Rawls's NPI?
Dr. Dejuania Brown-Rawls's National Provider Identifier (NPI) is 1730379132, issued by NPPES.
Does Dr. Dejuania Brown-Rawls accept Medicare assignment?
Yes. Dr. Dejuania Brown-Rawls accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Dejuania Brown-Rawls commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram (HCPCS Q5125); Injection, pembrolizumab, 1 mg (HCPCS J9271); Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS Q9967). Source: CMS Medicare Physician & Other Practitioners file.